Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pediatric low-grade gliomas; a 12-year retrospective review from a tertiary care hospital in LMIC.

Journal of neuro-oncology·2026

Same author

Primary Spinal Cord Tumors in Children: A Multi-institutional Retrospective Study from Pakistan.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2026

Same author

Experience of Pediatric Radiation Oncology Peer Review Meetings: First Step Toward Centralizing Pediatric Radiotherapy in Pakistan.

Pediatric blood & cancer·2026

Same author

Predictors of acute upper GI toxicity and its correlation with dosimetric analysis in patients receiving adjuvant radiation therapy for breast cancer.

Ecancermedicalscience·2026

Same author

Peripheral T-cell lymphoma of the lip: a rare case unveiling key insights into diagnosis and management.

Ecancermedicalscience·2026

Same author

Evaluating the Impact of Transitioning from Weekly to Daily Peer Review in Radiation Oncology.

Asian Pacific journal of cancer prevention : APJCP·2025

Search research articles

Related Experiment Video

Updated: Nov 25, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Childhood Medulloblastoma.

Naureen Mushtaq¹, Shahzadi Resham², Shahzad Shamim³

¹Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan.

JPMA. the Journal of the Pakistan Medical Association

|December 20, 2020

Summary

This summary is machine-generated.

Medulloblastoma, a common pediatric brain tumor, is now classified into four genomic groups: Wingless, Sonic hedgehog, Group 3, and Group 4. This advanced classification impacts treatment and prognosis, especially in resource-limited settings.

Keywords:

Childhood brain tumours, Medulloblastoma, WNT, SHH.

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: Nov 25, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

Pediatric oncology
Neuro-oncology
Genomics

Background:

Medulloblastoma is the most frequent malignant pediatric brain tumor, causing significant mortality and morbidity globally, particularly in low- and middle-income countries.
Traditional risk stratification relied on clinical and histological factors, but recent genomic profiling has identified four distinct molecular subgroups: Wingless, Sonic hedgehog, Group 3, and Group 4.
Brain tumors are the second leading cause of childhood cancer, and their complex management requires a multidisciplinary team and specialized equipment, posing challenges in resource-limited areas.

Purpose of the Study:

To provide an updated review on the management of pediatric medulloblastoma.
To highlight the therapeutic and prognostic implications of new genomic sub-groupings.
To address the challenges in managing pediatric brain tumors in resource-limited settings, using Pakistan as a case study.

Main Methods:

Literature review of recent advancements in medulloblastoma classification and management.
Analysis of genomic approaches including gene expression profiling, micro-RNA profiling, and methylation arrays.
Discussion of diagnostic and management challenges in low-resource environments.

Main Results:

Medulloblastoma is now classified into four molecular subgroups: Wingless, Sonic hedgehog, Group 3, and Group 4.
These genomic subgroups have significant implications for treatment strategies and patient outcomes.
Limited resources and specialized equipment hinder effective diagnosis and management in many regions.

Conclusions:

The new genomic classification of medulloblastoma offers improved therapeutic and prognostic insights.
Multidisciplinary care and advanced diagnostic/treatment facilities are crucial for managing pediatric brain tumors.
Addressing resource limitations is essential to improve outcomes for children with medulloblastoma in underserved regions.